Ontology highlight
ABSTRACT:
SUBMITTER: Qin A
PROVIDER: S-EPMC5055165 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Qin Angel A Coffey David G DG Warren Edus H EH Ramnath Nithya N
Cancer medicine 20160715 9
In the past several years, immunotherapy has emerged as a viable treatment option for patients with advanced non-small cell lung cancer (NSCLC) without actionable driver mutations that have progressed on standard chemotherapy. We are also beginning to understand the methods of immune evasion employed by NSCLC which likely contribute to the 20% response rate to immunotherapy. It is also yet unclear what tumor or patient factors predict response to immunotherapy. The objectives of this review are ...[more]